Aimed to apply multicriteria decision analysis (MCDA) modelling to a range of drug harms in the UK. Heroin, crack cocaine, and metamfetamine were the most harmful drugs to individuals. Alcohol was the most harmful drug (overall harm score 72), with heroin (55) and crack cocaine (55).
Aimed to apply multicriteria decision analysis (MCDA) modelling to a range of drug harms in the UK. Heroin, crack cocaine, and metamfetamine were the most harmful drugs to individuals. Alcohol was the most harmful drug (overall harm score 72), with heroin (55) and crack cocaine (55).
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as TXT, PDF, TXT or read online from Scribd
Aimed to apply multicriteria decision analysis (MCDA) modelling to a range of drug harms in the UK. Heroin, crack cocaine, and metamfetamine were the most harmful drugs to individuals. Alcohol was the most harmful drug (overall harm score 72), with heroin (55) and crack cocaine (55).
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as TXT, PDF, TXT or read online from Scribd
Drug harms in the UK: a multicriteria decision analysis : The Lancet
RSS Feeds Welcome back, Miss RossSubscribe | My Lancet | Logout
[Close] Search for in All Fields Article Title, Abstract, Keywords Authors Article Title Abstract Advanced Search Home|JournalsThe LancetThe Lancet Infectious DiseasesThe Lancet NeurologyThe Lancet Oncology|Collections|Audio|ConferencesThe Lancet ConferencesConference CollaborationsMeet the Editors at Conferences|EducationAt The LimitsThe Lancet Core Clinical Collection|Resour ce CentresThe Lancet SeriesThe Lancet StudentH1N1 Influenza|For AuthorsWriting for The LancetWriting for The Lancet Infectious DiseasesWriting for The Lancet NeurologyWriting for The Lancet OncologyAbout Protocol ReviewsAccepted Protocol Summaries|Careers outline goes here The Lancet, Early Online Publication, 1 November 2010doi:10.1016/S0140-6736(10)61462-6Cite or Link Using DOIDrug harms in the UK: a multicriteria decision analysis Original Text Prof David J Nutt FMedSci a , Leslie A King PhD b, Lawrence D Phillips PhD c, on
behalf of the Independent Scientific Committee on Drugs